Fintel reports that on February 14, 2025, Wells Fargo initiated coverage of DENTSPLY SIRONA (NasdaqGS:XRAY) with a Equal-Weight recommendation. As of January 29, 2025, the average one-year price ...
Dentsply Sirona initiated a process to evaluate strategic alternatives for its Wellspect Healthcare business. Wellspect, a provider of bladder and bowel management care products, has an estimated ...
On in the Dutchman’s place was Endo but he was on the receiving end of a high challenge from Julio Enciso, who himself was a second half substitute. The Ipswich debutant was shown a yellow card ...
Endo's slide into bankruptcy follows in the footsteps of Purdue Pharma – which filed in 2019 but is still negotiating opioid settlement and corporate restructuring terms – as well as ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Some studies showed, that this kind of over instrumentation as well as under instrumentation can negatively affect the outcome of the endodontic ... VDW.Gold RECIPROC motor, the EndoPilot and ...
But another substitute, Wataru Endo, also deserved the spotlight after a typically battling cameo. And after seeing Liverpool to another big three points, Endo reaffirmed his commitment to the cause.
The global endodontics and orthodontics market is experiencing a rapid surge, with market analysts forecasting a steady Compounded Annual Growth Rate (CAGR) of 5.3% from 2022 to 2032. Sales in this ...
2. The investigation follows a class-action lawsuit filed against Dentsply Sirona in November alleging securities fraud. 3. The lawsuit alleges that Dentsply Sirona and certain executive officers made ...
Wataru Endo faces an uncertain future at Liverpool heading into the 2025/26 campaign. The Japanese star was brought to Anfield during the summer of 2023 as Jurgen Klopp looked to add to his midfield ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results